What happened with the Hazer (ASX:HZR) share price today?

The Hazer (ASX: HZR) share price closed slightly lower today after the company announced new commencement of works. We take a closer look.

| More on:
A man holds his hands out and shrugs.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Hazer Group Ltd (ASX: HZR) share price closed slightly down today after the company announced the start of new works at its Woodman Point treatment facility.

Shares in the hydrogen producer were trading 0.38% lower at a price of $1.29 when the market closed today.

It comes on the back of a positive year for the company that has seen its share price rise 323%. In comparison, the All Ordinaries Index (ASX: XAO) has gained 38.8% in the same period.

What happened

This morning, the Hazer share price was trading lower despite the announcement of new works at the company's wastewater treatment facility. The work will involve the mobilisation of equipment, cite clearing and civil earthworks which will start this week.

It's possible that Hazer's falling share price is a result of cost revisions for the project. The company advised that the project has seen some price increases, with the expected final cost now estimated at between 5% and 10% above its initial cost estimate of $17 million. 

The company attributed the price blowout to a number of factors, including the increased cost for the reactor and furnace packages. Hazer also chose to revise the design in a more complex manner to enable the company to deal with the required process conditions and engineering costs more safely.

Moreover, increased labour and equipment costs as a result of COVID-19 have also pushed up the pricetag. As such, the company estimates that the plant will now cost between $17.9 and $18.7 million.

Management comments

Commenting on the update, Hazer Group CEO Geoff Ward said:

We continue to make strong progress on the CDP with finalisation of key aspects of the technical design and commencement of earthworks.

As a first-of-kind project, the technical challenges are significant, but I am delighted by the way the Hazer team has worked with industry experts, suppliers and universities to resolve these challenges and deliver a robust design for the Hazer project.

Motley Fool contributor Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Two workers at an oil rig discuss operations.
Broker Notes

Should you buy Santos, Beach Energy or Woodside shares? Here's Macquarie's top pick

Macquarie has released its new share price expectations for Santos, Beach Energy and Woodside shares.

Read more »

A green fully charged battery symbol surrounded by green charge lights representing the surging Vulcan share price today
Share Market News

Up 300% in 6 months! This soaring ASX lithium stock just took a major step to production

Marching forward.

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Share Market News

Macquarie says this top ASX tech stock could rise 15%

Let's see what the broker is saying about this stock.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Collins Foods, Monash IVF, Premier Investments, and Step One shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Share Gainers

4 ASX 200 stocks smashing the benchmark this week

Investors have been piling into these four ASX 200 stocks this week. Let’s see why.

Read more »